Long-Acting Reversible Contraceptives for Incarcerated Women: Feasibility and Safety of On-Site Provision

Carolyn Sufrin, Tianyi Oxnard, Joe Goldenson, Kristin Simonson, Andrea Jackson

Research output: Contribution to journalArticle

Abstract

CONTEXT: Many incarcerated women have an unmet need for contraception. Providing access to long-acting reversible contraceptive (LARC) methods-IUDs and implants-before release is one strategy to meet this need and potentially prepare them for reentry to the community, but the safety and feasibility of providing these methods in this setting have not been described. METHODS: A retrospective descriptive study of all LARC insertions at the San Francisco County Jail in 2009-2014 was conducted. Data from community clinic and jail clinic databases were assessed to examine baseline characteristics of LARC initiators, complications from insertion, method continuation, and pregnancy and reincarceration rates. Correlates of method discontinuation were assessed in multivariate logistic regression analyses. RESULTS: Eighty-seven LARC devices were inserted during the study period-53 IUDs and 34 implants. There were no cases of pelvic inflammatory disease or other insertion complications in IUD users and no serious complications in implant users. Median duration of known use was 11.4 months for IUDs and 12.9 months for implants. Women who discontinued a LARC method most commonly cited a desire to get pregnant (32%). Black women were more likely than whites to discontinue use (odds ratio, 4.4). CONCLUSIONS: It is safe and feasible to provide LARC methods to incarcerated women. Correctional facilities should consider increasing access to all available contraceptives, including LARC methods, in a noncoercive manner as a strategy to reduce reproductive health disparities among marginalized women at high risk of unplanned pregnancies.

Original languageEnglish (US)
Pages (from-to)203-211
Number of pages9
JournalPerspectives on Sexual and Reproductive Health
Volume47
Issue number4
DOIs
StatePublished - Dec 1 2015

Fingerprint

Contraceptive Agents
Contraception
contraceptive
Safety
Contraceptive Devices
Unplanned Pregnancy
High-Risk Pregnancy
Pelvic Inflammatory Disease
Intrauterine Devices
San Francisco
Reproductive Health
pregnancy
Pregnancy Rate
Retrospective Studies
Logistic Models
Odds Ratio
Regression Analysis
Databases
contraception
community

ASJC Scopus subject areas

  • Sociology and Political Science
  • Obstetrics and Gynecology
  • Public Health, Environmental and Occupational Health

Cite this

Long-Acting Reversible Contraceptives for Incarcerated Women : Feasibility and Safety of On-Site Provision. / Sufrin, Carolyn; Oxnard, Tianyi; Goldenson, Joe; Simonson, Kristin; Jackson, Andrea.

In: Perspectives on Sexual and Reproductive Health, Vol. 47, No. 4, 01.12.2015, p. 203-211.

Research output: Contribution to journalArticle

Sufrin, Carolyn ; Oxnard, Tianyi ; Goldenson, Joe ; Simonson, Kristin ; Jackson, Andrea. / Long-Acting Reversible Contraceptives for Incarcerated Women : Feasibility and Safety of On-Site Provision. In: Perspectives on Sexual and Reproductive Health. 2015 ; Vol. 47, No. 4. pp. 203-211.
@article{29cd34922a0346e4adb650857ab3ed33,
title = "Long-Acting Reversible Contraceptives for Incarcerated Women: Feasibility and Safety of On-Site Provision",
abstract = "CONTEXT: Many incarcerated women have an unmet need for contraception. Providing access to long-acting reversible contraceptive (LARC) methods-IUDs and implants-before release is one strategy to meet this need and potentially prepare them for reentry to the community, but the safety and feasibility of providing these methods in this setting have not been described. METHODS: A retrospective descriptive study of all LARC insertions at the San Francisco County Jail in 2009-2014 was conducted. Data from community clinic and jail clinic databases were assessed to examine baseline characteristics of LARC initiators, complications from insertion, method continuation, and pregnancy and reincarceration rates. Correlates of method discontinuation were assessed in multivariate logistic regression analyses. RESULTS: Eighty-seven LARC devices were inserted during the study period-53 IUDs and 34 implants. There were no cases of pelvic inflammatory disease or other insertion complications in IUD users and no serious complications in implant users. Median duration of known use was 11.4 months for IUDs and 12.9 months for implants. Women who discontinued a LARC method most commonly cited a desire to get pregnant (32{\%}). Black women were more likely than whites to discontinue use (odds ratio, 4.4). CONCLUSIONS: It is safe and feasible to provide LARC methods to incarcerated women. Correctional facilities should consider increasing access to all available contraceptives, including LARC methods, in a noncoercive manner as a strategy to reduce reproductive health disparities among marginalized women at high risk of unplanned pregnancies.",
author = "Carolyn Sufrin and Tianyi Oxnard and Joe Goldenson and Kristin Simonson and Andrea Jackson",
year = "2015",
month = "12",
day = "1",
doi = "10.1363/47e5915",
language = "English (US)",
volume = "47",
pages = "203--211",
journal = "Perspectives on Sexual and Reproductive Health",
issn = "1538-6341",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Long-Acting Reversible Contraceptives for Incarcerated Women

T2 - Feasibility and Safety of On-Site Provision

AU - Sufrin, Carolyn

AU - Oxnard, Tianyi

AU - Goldenson, Joe

AU - Simonson, Kristin

AU - Jackson, Andrea

PY - 2015/12/1

Y1 - 2015/12/1

N2 - CONTEXT: Many incarcerated women have an unmet need for contraception. Providing access to long-acting reversible contraceptive (LARC) methods-IUDs and implants-before release is one strategy to meet this need and potentially prepare them for reentry to the community, but the safety and feasibility of providing these methods in this setting have not been described. METHODS: A retrospective descriptive study of all LARC insertions at the San Francisco County Jail in 2009-2014 was conducted. Data from community clinic and jail clinic databases were assessed to examine baseline characteristics of LARC initiators, complications from insertion, method continuation, and pregnancy and reincarceration rates. Correlates of method discontinuation were assessed in multivariate logistic regression analyses. RESULTS: Eighty-seven LARC devices were inserted during the study period-53 IUDs and 34 implants. There were no cases of pelvic inflammatory disease or other insertion complications in IUD users and no serious complications in implant users. Median duration of known use was 11.4 months for IUDs and 12.9 months for implants. Women who discontinued a LARC method most commonly cited a desire to get pregnant (32%). Black women were more likely than whites to discontinue use (odds ratio, 4.4). CONCLUSIONS: It is safe and feasible to provide LARC methods to incarcerated women. Correctional facilities should consider increasing access to all available contraceptives, including LARC methods, in a noncoercive manner as a strategy to reduce reproductive health disparities among marginalized women at high risk of unplanned pregnancies.

AB - CONTEXT: Many incarcerated women have an unmet need for contraception. Providing access to long-acting reversible contraceptive (LARC) methods-IUDs and implants-before release is one strategy to meet this need and potentially prepare them for reentry to the community, but the safety and feasibility of providing these methods in this setting have not been described. METHODS: A retrospective descriptive study of all LARC insertions at the San Francisco County Jail in 2009-2014 was conducted. Data from community clinic and jail clinic databases were assessed to examine baseline characteristics of LARC initiators, complications from insertion, method continuation, and pregnancy and reincarceration rates. Correlates of method discontinuation were assessed in multivariate logistic regression analyses. RESULTS: Eighty-seven LARC devices were inserted during the study period-53 IUDs and 34 implants. There were no cases of pelvic inflammatory disease or other insertion complications in IUD users and no serious complications in implant users. Median duration of known use was 11.4 months for IUDs and 12.9 months for implants. Women who discontinued a LARC method most commonly cited a desire to get pregnant (32%). Black women were more likely than whites to discontinue use (odds ratio, 4.4). CONCLUSIONS: It is safe and feasible to provide LARC methods to incarcerated women. Correctional facilities should consider increasing access to all available contraceptives, including LARC methods, in a noncoercive manner as a strategy to reduce reproductive health disparities among marginalized women at high risk of unplanned pregnancies.

UR - http://www.scopus.com/inward/record.url?scp=84949963009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949963009&partnerID=8YFLogxK

U2 - 10.1363/47e5915

DO - 10.1363/47e5915

M3 - Article

C2 - 26484795

AN - SCOPUS:84949963009

VL - 47

SP - 203

EP - 211

JO - Perspectives on Sexual and Reproductive Health

JF - Perspectives on Sexual and Reproductive Health

SN - 1538-6341

IS - 4

ER -